Abstract:Background: Chronic use of mu-opioid receptor agonists paradoxically causes both hyperalgesia and the loss of analgesic efficacy. Opioid treatment increases presynaptic N-methyl-d-aspartate receptor activity to potentiate nociceptive input to spinal dorsal horn neurons. However, the mechanism responsible for this opioid- induced activation of presynaptic N-methyl-d-aspartate receptors remains unclear. alpha 2 delta-1, formerly known as a calcium channel subunit, interacts with N-methyl-d-aspartate receptors and is primarily expressed at presynaptic terminals. This study tested the hypothesis that alpha 2 delta-1-bound N-methyl-d-aspartate receptors contribute to presynaptic N-methyl-d-aspartate receptor hyperactivity associated with opioid-induced hyperalgesia and analgesic tolerance. Methods: Rats (5 mg/kg) and wild-type and alpha 2 delta-1-knockout mice (10 mg/kg) were treated intraperitoneally with morphine twice/day for 8 consecutive days, and nociceptive thresholds were examined. Presynaptic N-methyl-d-aspartate receptor activity was recorded in spinal cord slices. Coimmunoprecipitation was performed to examine protein-protein interactions. Results: Chronic morphine treatment in rats increased alpha 2 delta-1 protein amounts in the dorsal root ganglion and spinal cord. Chronic morphine exposure also increased the physical interaction between alpha 2 delta-1 and N-methyl-d-aspartate receptors by 1.5 +/- 0.3 fold (means +/- SD, P = 0.009, n = 6) and the prevalence of alpha 2 delta-1-bound N-methyl-d-aspartate receptors at spinal cord synapses. Inhibiting alpha 2 delta-1 with gabapentin or genetic knockout of alpha 2 delta-1 abolished the increase in presynaptic N-methyl-d-aspartate receptor activity in the spinal dorsal horn induced by morphine treatment. Furthermore, uncoupling the alpha 2 delta-1-Nmethyl- d-aspartate receptor interaction with an alpha 2 delta-1 C terminus-interfering peptide fully reversed morphine-induced tonic activation of N-methyl-d-aspartate receptors at the central terminal of primary afferents. Finally, intraperitoneal injection of gabapentin or intrathecal injection of an alpha 2 delta-1 C terminus-interfering peptide or alpha 2 delta-1 genetic knockout abolished the mechanical and thermal hyperalgesia induced by chronic morphine exposure and largely preserved morphine's analgesic effect during 8 days of morphine treatment. Conclusions: alpha 2 delta-1-Bound N-methyl-d-aspartate receptors contribute to opioid-induced hyperalgesia and tolerance by augmenting presynaptic N-methyl-d-aspartate receptor expression and activity at the spinal cord level.

Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.

Effects and Mechanisms of Supraspinal Administration of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on Nociception in Mice

Effects of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on the Antinociceptive Activity of Pethidine Administered at the Peripheral and Supraspinal Level

Influence Of Clonidine And Ketamine On M-Rna Expression In A Model Of Opioid-Induced Hyperalgesia In Mice

In Vivo Characterization of the Effects of Human Hemokinin-1 and Human Hemokinin-1(4-11), Mammalian Tachykinin Peptides, on the Modulation of Pain in Mice

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

Cardiovascular Responses to Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide: Systemic Study in Anesthetized Rats

Pain Regulation of Endokinin A/B or Endokinin C/D on Chimeric Peptide MCRT in Mice.

Effects of Endokinin A/B and Endokinin C/D on the Antinociception of Endomorphin-1 in Mice

In Vitro Characterization of the Effects of Rat/mouse Hemokinin-1 on Mouse Colonic Contractile Activity: a Comparison with Substance P.

Analgesic Tolerance and Cross-Tolerance to the Cannabinoid Receptors Ligands Hemopressin, VD-hemopressin(α) and WIN55,212-2 at the Supraspinal Level in Mice

Hemokinin-1 induces transcriptomic alterations in pain-related signaling processes in rat primary sensory neurons independent of NK1 tachykinin receptor activation

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

Effects of Endokinin A/B and Endokinin C/D on the Antinociception Properties of Hemopressin in Mice

Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(M)vd-Hemopressin(α)], an N-terminally Extended Hemopressin Peptide.

Morphine-responsive neurons that regulate mechanical antinociception

CB1 Cannabinoid Receptor Agonist Mouse VD-hemopressin(α) Produced Supraspinal Analgesic Activity in the Preclinical Models of Pain.

Oligomerization of MrgC11 and Μ-Opioid Receptors in Sensory Neurons Enhances Morphine Analgesia.

Effects of Endokinin A/B and Endokinin C/D on the modulation of pain in mice.

Pharmacological Characterization of Rat VD-hemopressin(α), an Α-Hemoglobin-derived Peptide Exhibiting Cannabinoid Agonist-Like Effects in Mice

Α2δ-1–Boundn-methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents